Viewing Study NCT04075292


Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2026-03-18 @ 10:07 PM
Study NCT ID: NCT04075292
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-21
First Post: 2019-08-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia
Sponsor: AstraZeneca
Organization: